Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients.
Conditions: Head Neck Cancer; Radiation Neuropathy; Pain, Neuropathic Interventions: Drug: Gabapentin; Other: Placebo Sponsors: University Hospital, Ghent; General Hospital Groeninge; Catholic University Leuven (Kulak), Kortrijk, Belgium; Anglia Ruskin University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Belgium Health | Brain | Cancer | Cancer & Oncology | Gabapentin | Head and Neck Cancer | Hospitals | Neurology | Neurontin | Pain | Research | Study